Progressive multifocal leukoencephalopathy in systemic lupus erythematosus treated with pembrolizumab
- 19 September 2024
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 17 (9) , e260624
Abstract
This case report discusses a patient with systemic lupus erythematosus (SLE) treated with low-dose azathioprine who developed progressive multifocal leukoencephalopathy (PML). PML is a rare, severe, demyelinating disease linked to John Cunningham polyomavirus (JCV) reactivation. Treated with pembrolizumab, an immune checkpoint inhibitor, the patient initially improved. However, after the fourth dose, her condition rapidly worsened resulting in treatment discontinuation and death. Similar cases highlight the complex interplay of factors in PML development in SLE patients, including immunosuppression and genetic factors. The use of pembrolizumab in PML and SLE necessitates careful consideration of potential complications.Keywords
This publication has 13 references indexed in Scilit:
- Immune‐related adverse events after immune check point inhibitors: Understanding the intersection with autoimmunityImmunological Reviews, 2023
- Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint InhibitorsAnnals of Neurology, 2022
- Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse ReactionsThe Lancet Haematology, 2021
- Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related diseaseNature Reviews Neurology, 2020
- Precision medicine for rheumatologists: lessons from the pharmacogenomics of azathioprineClinical Rheumatology, 2020
- Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort StudyArthritis & Rheumatology, 2019
- Pembrolizumab Treatment for Progressive Multifocal LeukoencephalopathyNew England Journal of Medicine, 2019
- Haematological manifestations of lupusLupus Science & Medicine, 2015
- Increased Program Cell Death–1 Expression on T Lymphocytes of Patients With Progressive Multifocal LeukoencephalopathyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Progressive multifocal leukoencephalopathy: A national estimate of frequency in systemic lupus erythematosus and other rheumatic diseasesArthritis & Rheumatism, 2009